Share

Curus invests in Wellon

20 Sep - 2023

Investment company Curus has made an investment in health start-up Wellon. Wellon offers a service where consumers can be tested for the need for specific vitamins, minerals and other supplements. After analysis, a food supplement package is tailored and delivered monthly to the customer in convenient sachets.

There is a clear trend of more and more people seeking tailor-made solutions for their supplements, especially with new supplements constantly entering the market. For vitamins and supplements to be truly effective, they need to be tailored to your body and lifestyle. Wellon has solved this by making its nutritional recommendations personalized and easy to follow, and by using only supplements from well-known and proven brands. In addition, they have their own dispensing machinery, further strengthening their position in the market

“It is with great enthusiasm that we enter Wellon. It is clear that the field of dietary supplements is attracting increasing interest among the public and we look forward to being part of this journey with Wellon.” says Erik Olsson Nyrén, Investment Manager at Curus.

In the US, there are a number of major players similar to Wellon where many consumers are moving to tailored solutions. Wellon intends to launch its service in Europe and be one of the major players in the field.

Ylva Pagmén, CEO of Wellon, comments: “The company is going from strength to strength and we are seeing constant growth. Almost 60% of the population regularly take supplements, but many are unsure if they really need it or feel the frustration of managing many different jars and products. With our service we solve both of these problems.”

Jacob Versteegh, CEO of Bonver Group, one of the major shareholders in Wellon, is also positive about Curus’ investment: “We are very pleased that Curus has chosen to invest in Wellon. It underlines the potential and value we see in the company and its service.”

For more information
Erik Olsson Nyrén, Investment Manager Curus,
[email protected],+46 70 837 73 54

Johan Bloom, CEO Curus,
[email protected],+46 733 648 490

Ylva Pagmén, CEO Wellon,
[email protected],+46 70 476 85 22

Jacob Versteegh, CEO Bonver Group,
[email protected],+46 70 976 08 60

 

About Curus
Curus is an investment company investing in the Nordic region with a particular focus on digital health and healthcare. Curus has the opportunity to make both minority and majority investments and can contribute both capital, industry experience and networks as well as marketing to our portfolio companies. Curus has investments in 5 majority-owned companies and a minority stake in 22 growth companies. For more information, see www.curus.se.

About Wellon
Wellon is a health startup focused on personalized nutritional supplements. By offering consumers tests and personalized recommendations, the company aims to make it easier and more effective for individuals to achieve optimal health. For more information, see www.wellon.se.

More news

23 Sep - 2024

Test posts

7 Nov - 2023

Successful health initiative in Region Stockholm exceeds target – more than 50% out of type 2 diabetes risk zone

4 Sep - 2023

Curus Invests in Measurlabs, a Finnish Laboratory Analysis Platform

This website uses cookies to ensure you get the best experience on our website.